QA: Aquestive Therapeutics Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001398733_2026_Aquestive_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001398733, Aquestive Therapeutics Inc

  xvar xval
0 AssetsCurrent 149,269,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 3,893,000
3 remainder_Assets 7,263,000
4 LiabilitiesCurrent 47,608,000
5 LiabilitiesNoncurrent 30,996,000
6 remainder_Liabilities 115,483,000
7 CostOfGoodsAndServicesSold 18,398,017
8 SellingGeneralAndAdministrativeExpense 78,408,961
9 ResearchAndDevelopmentExpense 17,663,354
10 remainder_Expenses 17,039,572
11 remainder_Revenues 46,777,036
12 remainder_NetIncome 4,133,410
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 160,425,000
1 Liabilities 194,087,000
2 Expenses 131,509,904
3 Revenues 46,777,036
4 StockholdersEquity -33,662,000
5 NetIncome -80,599,458
6 ComprehensiveNetIncome -80,599,458
7 BaseVar 268,466,175
8 EconomicCapitalRatiobeforeLimitedLiability -0.869
9 EconomicCapitalRatio 1.33

Edgar->Model Mapping

Feature Distribution

Change over Time